Gartner Positions Cigniti Technologies as a “Challenger” in Magic Quadrant for Application Testing Services, Worldwide
Cigniti Technologies, a leading provider of independent software testing services globally, today announced that it has been positioned as a “Challenger” in the Gartner’s 2015 Magic Quadrant for Application Testing Services, Worldwide.1
“We are excited to be positioned as a Challenger in the Gartner’s Magic Quadrant for Application Testing Services and to be assessed for our specialized & IP led software testing services, test automation tools, and flexible delivery models. We believe this achievement further elevates us as a preferred software testing partner for global enterprises and independent software vendors,” says Pradeep Govindasamy – CTO & President, Cigniti Technologies in North America. “We continue to innovate and invest in our end-to-end quality engineering services, which are enabling digital transformation in global enterprises leveraging our SMART Tools™, labs and agile processes, that help our customers accelerate time to market, deliver unparalleled customer experience through superior software and retain their competitive advantage.”
The Magic Quadrant Report assesses 17 of the leading application service providers based on specified inclusion criteria. It reviews each provider's strengths and cautions in the application testing service categories, as well as emphasizes the areas the providers are strong in and the areas that need improvement.
“This recognition as a Challenger in the Gartner’s Magic Quadrant is a game changer for Cigniti and helps us move closer to achieving our goal of becoming the world’s largest and most respected independent software testing services company, which reflects our ability to deliver sustained growth. It is a testimony of strong relationships we have with our clients and trust they have in our specialized testing services,” says Srikanth Chakkilam – Executive Director, Cigniti Technologies. “It strengthens our position to serve global companies across the rest of the world markets that we currently serve, which include UK, EMEA, ANZ and Asia.”
Gartner defines Application Testing Services as “a comprehensive term used to capture all types of verification and validation services for the purposes of supporting quality control and quality assurance (QA) of clients' applications. Verification assesses the technical behavior, and validation assesses the functional behavior of tested elements.”
“The application testing service market, with a copious number of providers, is fast-growing. Both full IT services providers and dedicated, pure-play application testing service providers coexist. By 2018, agile and iterative development will require 30% of resources for application testing engagements to be on-site or onshore,” Gartner says.
Please visit http://www.cigniti.com/analyst-commentary-by-Gartner to view the full report.
About the Magic Quadrant
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Cigniti Technologies Limited (BSE: 534758, www.cigniti.com), Global Leaders in Independent Software Testing (IST) Services, is headquartered at Hyderabad, India. Cigniti’s 1800+ experts are spread across US, UK, India, Australia, and Canada. Cigniti is the world’s first IST Services Company to be appraised at CMMI-SVC v1.3, Maturity Level 5, and is also ISO 9001:2008 & ISO 27001:2013 certified. Cigniti’s test offerings include services in Quality Engineering, Advisory & Transformation, Next Generation Testing, and Core Testing. With over a decade of experience in serving several 500 fortune enterprises, Cigniti has translated its learning and solutions into SMART Tools™ to accelerate test efforts. Cigniti has India's first of its kind Robotics Test Lab, a Mobile Cloud Test Lab with HP & Experitest, a Cloud enabled Performance Test Lab, and an IoT & Smart Meter Lab. Leading Analysts like Gartner, Forrester, NelsonHall, Everest, Frost & Sullivan, and Forbes recognize Cigniti as a leader in the IST Services space. Cigniti has been awarded a place on the Crown Commercial Service (CCS) G-Cloud 6 framework for providing Lot 4: Specialist Cloud Services that provide PSEs better access to Cigniti's expertise. Cigniti’s CSR initiative, Project Cignificance, aims to impact 1 million+ lives through education as an enabler. For more information write to firstname.lastname@example.org.
1 Gartner “Magic Quadrant for Application Testing Services, Worldwide” by Susanne Matson, Patrick J. Sullivan, 23 November 2015
For Cigniti Technologies
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and